Cover Image
市場調查報告書

美國的麻醉劑市場與預測

United States Anesthesia Drugs Market & Forecast

出版商 Renub Research 商品編碼 320845
出版日期 內容資訊 英文 74 Pages; 56 Figures & 1 Table
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的麻醉劑市場與預測 United States Anesthesia Drugs Market & Forecast
出版日期: 2014年12月11日 內容資訊: 英文 74 Pages; 56 Figures & 1 Table
簡介

美國的麻醉劑市場到2018年預計達到30億美元以上。該市場中,依照市場區隔,全身靜脈麻醉劑市場具支配性。全身靜脈麻醉劑再分類的話,Propofol及苯重氮基鹽級的麻醉劑佔很大的佔有率。局部麻醉劑市場區隔,利多卡因構成最大的佔有率。

本報告提供美國的麻醉劑市場相關調查、市場佔有率與預測、各種類、藥物的市場分析、市場成長的促進要素與課題,及主要企業簡介等彙整,為您概述為以下內容。

第1章 摘要整理

第2章 美國的麻醉劑市場

第3章 美國的麻醉劑市場佔有率與預測

  • 麻醉劑市場佔有率與預測:各類型
  • 全身靜脈麻醉劑市場佔有率與預測
  • 局部麻醉劑市場佔有率與預測
  • 麻醉劑市場佔有率與預測:各企業

第4章 各類型:美國的麻醉劑市場

  • 全身吸入麻醉劑市場
  • 全身靜脈麻醉劑市場
  • 局部麻醉劑市場

第5章 各藥物:美國的全身靜脈麻醉劑市場

  • Propofol市場
  • 苯重氮基鹽級(Diazepam、Midazolam)市場
  • Fospropofol Disodium市場
  • Ketamine(K他命)市場
  • Methohexital Sodium市場
  • Pentobarbital市場
  • Etomidate市場
  • Fentanyl市場

第6章 各藥物:美國的局部麻醉劑市場

  • Articaine市場
  • Bupivacaine市場
  • 利多卡因市場
  • Mepivacaine市場
  • Prilocaine市場

第7章 美國的麻醉劑市場上主要企業簡介

  • Baxter International Inc.:麻醉劑的銷售額與預測
  • Endo Health Solutions Inc.:麻醉劑的銷售額與預測
  • Abbott Laboratories:麻醉劑的銷售額與預測
  • AstraZeneca:麻醉劑的銷售額與預測

第8章 美國的麻醉劑市場:促進成長要素

  • 麻醉服務的需求增加
  • 美國的高齡化人口、心血管疾病罹患率的增加

第9章 美國的麻醉劑市場:課題

  • 美國的麻醉供應商的不足
  • 美國的麻醉劑的不足

圖表清單

目錄

Anesthesia drugs are used during tests and surgical operations to induce sleep, which prevents pain and discomfort and enables a wide range of medical procedures to be performed. Local Anesthesia and General Anesthesia are the two commonly used types of anesthesia. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation.

United States anesthesia drugs market is expected to be more than US$ 3 Billion by 2018. General Intravenous Anesthesia drugs market is dominating the United States anesthesia drugs market. In further classification of General Intravenous Anesthesia Drugs market, Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top contributors to intravenous anesthetic drugs in the United States anesthesia drugs market. In classification of Local Anesthesia Drugs Market Share Lidocaine holds the maximum market share. From companies analysis part Baxter International Inc, Endo Health Solutions Inc and Abbott Laboratories are three main players, but Others companies also play a major role in United States anesthesia drugs market.

Renub Research report titled "nesthesia Drugs Market & Forecast" provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 74 page report with 56 Figures and 1 Table provides a complete analysis of local and general anesthesia drugs market in United States. This report has been studied from 2 viewpoints.

  • 1. General Anesthesia Drugs Market
  • 2. Local Anesthesia Drugs Market

General Intravenous Anesthetic Drugs Market has been further divided into

  • 1. Propofol
  • 2. Benzodiazepines Class (Diazepam and Midazolam)
  • 3. Fospropofol Disodium
  • 4. Ketamine
  • 5. Methohexital Sodium
  • 6. Pentobarbital
  • 7. Etomidate
  • 8. Fentanyl

United States Local Anesthetic Market has been further divided into

  • 1. Articane
  • 2. Bupivacaine
  • 3. Lidocaine
  • 4. Mepivacaine
  • 5. Prilocaine

Key Players Profile in United States Anesthetic Drugs Market

  • 1. Baxter International Inc
  • 2. Endo Health Solutions Inc
  • 3. Abbott Laboratories
  • 4. AstraZeneca

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. United States Anesthesia Drugs Market (2010 - 2018)

3. United States Anesthesia Drugs Market Share & Forecast (2010 - 2018)

  • 3.1 United States Anesthesia Drugs Market Share & Forecast by Type (2010 - 2018)
  • 3.2 United States General Intravenous Anesthesia Drugs Market Share & Forecast (2010 - 2018)
  • 3.3 United States Local Anesthesia Drugs Market Share & Forecast (2010 - 2018)
  • 3.4 United States Anesthesia Drugs Market Share & Forecast by Company (2010 - 2018)

4. By Type - United States Anesthesia Drugs Market (2008 - 2018)

  • 4.1 United States General Inhalation Anesthesia Drugs Market (2008 - 2018)
  • 4.2 United States General Intravenous Anesthesia Drugs Market (2008 - 2018)
  • 4.3 United States Local Anesthesia Drugs Market (2008 - 2018)

5. By Drugs - United States General Intravenous Anesthesia Drugs Market (2010 - 2018)

  • 5.1 United States Propofol Market (2010 - 2018)
  • 5.2 United States Benzodiazepines Class (Diazepam and Midazolam) Market (2010 - 2018)
  • 5.3 United States Fospropofol Disodium Market (2010 - 2018)
  • 5.4 United States Ketamine Market (2010 - 2018)
  • 5.5 United States Methohexital Sodium Market (2010 - 2018)
  • 5.6 United States Pentobarbital Market (2010 - 2018)
  • 5.7 United States Etomidate Market (2010 - 2018)
  • 5.8 United States Fentanyl Market (2010 - 2018)

6. By Drugs - United States Local Anesthesia Drugs Market (2008 - 2018)

  • 6.1 United States Articaine Market (2008 - 2018)
  • 6.2 United States Bupivacaine Market (2008 - 2018)
  • 6.3 United States Lidocaine Market (2008 - 2018)
  • 6.4 United States Mepivacaine Market (2008 - 2018)
  • 6.5 United States Prilocaine Market (2008 - 2018)

7. Key Players Profile in United States Anesthesia Drugs Market

  • 7.1 Baxter International Inc. Anesthesia Drugs Sales & Forecast (2008 - 2018)
  • 7.2 Endo Health Solutions Inc. Anesthesia Drugs Sales & Forecast (2008 - 2018)
  • 7.3 Abbott Laboratories Anesthesia Drugs Sales & Forecast (2008 - 2018)
  • 7.4 AstraZeneca Anesthetic Drugs Sales (2009 - 2011)

8. United States Anesthesia Drugs Market - Growth Driver

  • 8.1 Increasing Demand for Anesthesia Service
  • 8.2 Increasing Ageing Population and Prevalence of Cardiovascular Disease in United States
  • 8.2.1 Increasing Ageing Population

9. United States Anesthesia Drugs Market - Challenges

  • 9.1 Shortage of Anesthesia Providers in United States
  • 9.2 Shortage of Anesthesia Drugs in United States

LIST OF FIGURES

  • Figure 2 1: United States - Anesthesia Drugs Market (Million US$), 2010 - 2013
  • Figure 2 2: United States - Forecast for Anesthesia Drugs Market (Million US$), 2014 - 2018
  • Figure 3 1: United States - Anesthesia Drugs Market Share by Type (Percent), 2010 - 2013
  • Figure 3 2: United States - Forecast for Anesthesia Drugs Market Share by Type (Percent), 2014 - 2018
  • Figure 3 3: United States - General Intravenous Anesthesia Drugs Market Share (Percent), 2010 - 2013
  • Figure 3 4: United States - Forecast for General Intravenous Anesthesia Drugs Market Share (Percent), 2014 - 2018
  • Figure 3 5: United States - Local Anesthesia Drugs Market Share (Percent), 2010 - 2013
  • Figure 3 6: United States - Forecast for Local Anesthesia Drugs Market Share (Percent), 2014 - 2018
  • Figure 3 7: United States - Anesthesia Drugs Market Share by Company (Percent), 2010 - 2013
  • Figure 3 8: United States - Forecast for Anesthesia Drugs Market Share by Company (Percent), 2014 - 2018
  • Figure 4 1: United States - General Inhalation Anesthesia Drugs Market (Million US$), 2008 - 2013
  • Figure 4 2: United States - Forecast for General Inhalation Anesthesia Drugs Market (Million US$), 2014 - 2018
  • Figure 4 3: United States - General Intravenous Anesthesia Drugs Market (Million US$), 2008 - 2013
  • Figure 4 4: United States - Forecast for General Intravenous Anesthesia Drugs Market (Million US$), 2014 - 2018
  • Figure 4 5: United States - Local Anesthesia Drugs Market (Million US$), 2008 - 2013
  • Figure 4 6: United States - Forecast for Local Anesthesia Drugs Market (Million US$), 2014 - 2018
  • Figure 5 1: United States - Propofol Market (Million US$), 2010 - 2013
  • Figure 5 2: United States - Forecast for Propofol Market (Million US$), 2014 - 2018
  • Figure 5 3: United States - Benzodiazepines Class Market (Million US$), 2010 - 2013
  • Figure 5 4: United States - Forecast for Benzodiazepines Class Market (Million US$), 2014 - 2018
  • Figure 5 5: United States - Fospropofol Disodium Market (Million US$), 2010 - 2013
  • Figure 5 6: United States - Forecast for Fospropofol Disodium Market (Million US$), 2014 - 2018
  • Figure 5 7: United States - Ketamine Market (Million US$), 2010 - 2013
  • Figure 5 8: United States - Forecast for Ketamine Market (Million US$), 2014 - 2018
  • Figure 5 9: United States - Methohexital Sodium Market (Million US$), 2010 - 2013
  • Figure 5 10: United States - Forecast for Methohexital Sodium Market (Million US$), 2014 - 2018
  • Figure 5 11: United States - Pentobarbital Market (Million US$), 2010 - 2013
  • Figure 5 12: United States - Forecast for Pentobarbital Market (Million US$), 2014 - 2018
  • Figure 5 13: United States - Etomidate Market (Million US$), 2010 - 2013
  • Figure 5 14: United States - Forecast for Etomidate Market (Million US$), 2014 - 2018
  • Figure 5 15: United States - Fentanyl Market (Million US$), 2010 - 2013
  • Figure 5 16: United States - Forecast for Fentanyl Market (Million US$), 2014 - 2018
  • Figure 6 1: United States - Articaine Market (Million US$), 2008 - 2013
  • Figure 6 2: United States - Forecast for Articane Market (Million US$), 2014 - 2018
  • Figure 6 3: United States - Bupivacaine Market (Million US$), 2008 - 2013
  • Figure 6 4: United States - Forecast for Bupivacaine Market (Million US$), 2014 - 2018
  • Figure 6 5: United States - Lidocaine Market (Million US$), 2008 - 2013
  • Figure 6 6: United States - Forecast for Lidocaine Market (Million US$), 2014 - 2018
  • Figure 6 7: United States - Mepivacaine Market (Million US$), 2008 - 2013
  • Figure 6 8: United States - Forecast for Mepivacaine Market (Million US$), 2014 - 2018
  • Figure 6 9: United States - Prilocaine Market (Million US$), 2008 - 2013
  • Figure 6 10: United States - Forecast for Prilocaine Market (Million US$), 2014 - 2018
  • Figure 7 1: United States - Baxter International Anesthesia Drugs Sales (Million US$), 2008 - 2013
  • Figure 7 2: United States - Forecast for Baxter International Anesthesia Drugs Sales (Million US$), 2014 - 2018
  • Figure 7 3: United States - Endo Health Solutions Anesthesia Drugs Sales (Million US$), 2008 - 2013
  • Figure 7 4: United States - Forecast for Endo Health Solutions Anesthesia Drugs Sales (Million US$), 2014 - 2018
  • Figure 7 5: United States - Abbott Laboratories Anesthesia Drugs Sales (Million US$), 2008 - 2013
  • Figure 7 6: United States - Forecast for Abbott Laboratories Anesthesia Drugs Sales (Million US$), 2014 - 2018
  • Figure 7 7: United States - AstraZeneca Anesthesia Drugs Sales (Million US$), 2009 - 2011
  • Figure 8 1: United States - Cosmetic Procedures (Number), 1997, 2012, 2013
  • Figure 8 2: United States - Number of Surgical Procedure (Thousand), 2007 - 2010
  • Figure 8 3: United States - Ageing Population by Age Group (Thousand), 2009 - 2012
  • Figure 9 1: United States - By Region Availability of Anesthesia Specialists (Percent), 2010
  • Figure 9 2: United States - By States Availability of Anesthesia Specialists (Percent), 2010
  • Figure 9 3: United States - Drugs Shortage (Number), 2006, 2011, 2012
  • Figure 9 4: United States - Anesthesia Drugs Shortage with the Highest Frequency (Percent), 2012

LIST OF TABLES

  • Table 8-1: United States - Cardiovascular Disease Prevalence (Percent), 2010,2015,2020,2025, 2030

KEY WORDS

Anesthesia, US anesthesia drugs market, anesthesia drugs, propofol, benzodiazepines class, fospropofol disodium, ketamine, methohexital sodium, pentobarbital, etomidate, fentanyl, articane, bupivacaine, lidocaine, mepivacaine, prilocaine, Baxter International, Endo Health Solutions, Abbott Laboratories, AstraZeneca

Back to Top